Paloma Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,830
Closed -$780K 1738
2021
Q2
$780K Buy
+4,830
New +$780K 0.01% 574
2017
Q3
Sell
-56,650
Closed -$207K 1820
2017
Q2
$207K Buy
+56,650
New +$207K ﹤0.01% 1468